Comparison of Lodoxamide 0.1% Ophthalmic Solution and Levocabastine 0.05% Ophthalmic Suspension in Vernal Keratoconjunctivitis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Ophthalmology

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/112067210101100203PMID 11456011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of Topical 0.05% Levocabastine and 0.1% Lodoxamide in Patients with Allergic Conjunctivitis

  1998cited by this paper
• Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA

  1998cited by this paper
• Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis

  1997influential reference
• New Directions in Therapy for Ocular Allergy

  1996cited by this paper
• Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.

  1995cited by this paper
• Levocabastine An Update of its Pharmacology, Clinical Efficacy and Tolerability in the Topical Treatment of Allergic Rhinitis and Conjunctivitis

  1995cited by this paper
• Efficacy of lodoxamide 0.1% ophthalmic solution in resolving corneal epitheliopathy associated with vernal keratoconjunctivitis.

  1994influential reference
• A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen‐provoked allergic conjunctivitis

  1993cited by this paper
• Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy.

  1993influential reference
• Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis

  1993cited by this paper
• Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.

  1992influential reference
• Randomised Double-Masked Trial of Lodoxamide and Sodium Cromoglycate in Allergic Eye Disease

  1992cited by this paper
• New directions in therapy for ocular allergy.

  1988cited by this paper
• [A classification of allergic conjunctivitis].

  1987cited by this paper
• Ocular allergy and mast cell stabilizers.

  1986influential reference
• The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma

  1986cited by this paper

• Recent updates on drug delivery approaches for improved ocular delivery with an insight into nanostructured drug delivery carriers for anterior and posterior segment disorders

  2024cites this paper
• Current perspectives on topical antiallergics

  2024cites this paper
• Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape.

  2023cites this paper
• Microneedle-based ocular drug delivery systems – recent advances and challenges

  2022cites this paper
• Efficacy of medical treatments for vernal keratoconjunctivitis: a systematic review and meta-analysis.

  2021cites this paper
• Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis

  2019cites this paper
• Current and emerging treatment options for vernal keratoconjunctivitis

  2017cites this paper
• Vernal keratoconjunctivitis: A severe allergic eye disease with remodeling changes

  2014cites this paper
• Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial.

  2014cites this paper
• Management of Vernal Keratoconjunctivitis

  2013cites this paper
• Utilità della citologia congiuntivale nella diagnosi e nel monitoraggio terapeutico della cheratocongiuntivite Vernal

  2013cites this paper
• Use of Cyclosporine A and Tacrolimus in Treatment of Vernal Keratoconjunctivitis

  2013cites this paper
• Modern Approach to Managing Vernal Keratoconjunctivitis

  2010cites this paper
• Tailored approach to the treatment of vernal keratoconjunctivitis.

  2010cites this paper
• [Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients].

  2010cites this paper
• Efficacia della Ciclosporina 1.25% per via topica (collirio) nel trattamento della Congiuntivite Vernal

  2010cites this paper
• Vernal keratoconjunctivitis: a major review

  2009cites this paper
• Ocular Allergy: Clinical, Therapeutic and Drug Discovery Considerations

  2008cites this paper
• Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children

  2008cites this paper
• Rapid Responses

  2007cites this paper
• Clinical grading of vernal keratoconjunctivitis

  2007cites this paper
• Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis

  2007cites this paper
• Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood

  2006cites this paper
• Spectrum of ocular allergy

  2002cites this paper